Compare fund portfolios
See how two funds' portfolios overlap. Enter two tickers:
FBT vs DLHAX
Shared holdings
17
FBT covered by DLHAX
23.71%
DLHAX covered by FBT
23.71%
Coverage = share of one portfolio's weight reproduced by the other (overlapping positions, min weight). Top 32 positions per side shown; = held by both — hover a shared position to highlight it in both columns.
FBT (March 31, 2026)
| Security | Weight | |
|---|---|---|
| MODERNA INC | 5.26% | |
| UNITED THERAPEUTICS CORP DEL | 4.36% | |
| ALKERMES PLC | 4.23% | |
| GILEAD SCIENCES INC | 4.09% | |
| AXSOME THERAPEUTICS INC | 3.88% | |
| AMGEN INC | 3.83% | |
| CORCEPT THERAPEUTICS INC | 3.82% | |
| KRYSTAL BIOTECH INC | 3.51% | |
| BIOGEN INC | 3.47% | |
| EXELIXIS INC | 3.46% | |
| NEUROCRINE BIOSCIENCES INC | 3.44% | |
| REGENERON PHARMACEUTICALS INC | 3.44% | |
| VERTEX PHARMACEUTICALS INC | 3.42% | |
| BIOMARIN PHARMACEUTICAL INC | 3.40% | |
| ARGENX SE SPONSORED ADR | 3.29% | |
| SAREPTA THERAPEUTICS INC | 3.24% | |
| HALOZYME THERAPEUTICS INC | 3.17% | |
| BIONTECH SE ADR | 3.16% | |
| INCYTE CORP | 3.13% | |
| BEONE MEDICINES LTD ADR | 3.12% | |
| ILLUMINA INC | 3.10% | |
| NATERA INC | 3.03% | |
| ACADIA PHARMACEUTICALS INC | 2.95% | |
| ALNYLAM PHARMACEUTICALS INC | 2.95% | |
| BIO-TECHNE CORP | 2.82% | |
| GENMAB A/S -SP ADR DEPOSITARY RECEIPT | 2.78% | |
| VERACYTE INC | 2.72% | |
| REPLIGEN CORP | 2.51% | |
| BRUKER CORP | 2.35% | |
| NEOGENOMICS INC | 2.00% | |
| DREY-GVT CSH-I | 0.06% | |
| DAIWA CAPITAL MARKETS AMERICA INC | 0.01% |
DLHAX (March 31, 2026)
| Security | Weight | |
|---|---|---|
| UCB SA | 5.91% | |
| REGENERON PHARMACEUTICALS INC | 5.47% | |
| PFIZER INC | 4.84% | |
| GILEAD SCIENCES INC | 4.41% | |
| ABBVIE INC | 4.10% | |
| MERCK & CO | 3.90% | |
| ASTRAZENECA PLC | 3.87% | |
| CHUGAI PHARMA CO | 3.74% | |
| LILLY ELI and CO | 3.60% | |
| ROCHE HOLDING AG | 3.31% | |
| UNITEDHEALTH GRP | 2.85% | |
| ELEVANCE HEALTH INC | 2.78% | |
| AMGEN INC | 2.49% | |
| VIATRIS INC | 2.38% | |
| BOSTON SCIENTIFIC CORP | 2.36% | |
| HALOZYME THERAPEUTICS INC | 2.14% | |
| Sanofi SA | 1.75% | |
| VERTEX PHARMACEUTICALS INC | 1.68% | |
| ILLUMINA INC | 1.67% | |
| VIKING THERAPEUTICS INC | 1.62% | |
| ALKERMES PLC | 1.54% | |
| ALNYLAM PHARMACEUTICALS INC | 1.50% | |
| FEDERAL NATIONAL MORTGAGE ASSOCIATION | 1.42% | |
| ROIVANT SCIENCES LTD | 1.41% | |
| NEUROCRINE BIOSCIENCES INC | 1.39% | |
| COGENT BIOSCIENCES INC | 1.33% | |
| ARCUS BIOSCIENCES INC | 1.23% | |
| INCYTE CORP | 1.13% | |
| ZIMMER BIOMET HO | 1.09% | |
| TARSUS PHARMACEUTICALS INC | 1.06% | |
| FREDDIE MAC | 1.01% | |
| QUEST DIAGNOSTICS INC | 0.89% | |
| BIOMARIN PHARMACEUTICAL INC | 0.85% | |
| CVS HEALTH CORP | 0.81% | |
| MONEYMKT | 0.81% | |
| BlackRock Liquidity FedFund - Institutional Class | 0.81% | |
| MSILF-GOVT-INS | 0.81% | |
| MONEYMKT | 0.81% | |
| ANAPTYSBIO INC | 0.78% | |
| BIOGEN INC | 0.77% | |
| Abivax SA SPONSORED ADS | 0.75% | |
| STRYKER CORP | 0.74% | |
| JOHNSON&JOHNSON | 0.74% | |
| VIR BIOTECHNOLOGY INC | 0.67% | |
| GRAIL INC | 0.66% | |
| RIGEL PHARMACEUTICALS INC | 0.65% | |
| UNIQURE N.V. | 0.64% | |
| SYNDAX PHARMACEUTICALS INC | 0.63% | |
| MADRIGAL PHARMACEUTICALS INC | 0.55% | |
| THERAVANCE BIOPHARMA INC | 0.51% |
Machine-readable: JSON · Markdown. Programmatic access via the agent surface.